ClinConnect ClinConnect Logo
Search / Trial NCT06781489

Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine.

Launched by UNIVERSIDAD EUROPEA DE MADRID · Jan 16, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well a combination of physical therapy, gabapentin, and ibuprofen arginine can help reduce pain in people with carpal tunnel syndrome, a condition that causes pain and discomfort in the hand and wrist. The researchers want to see if this combined treatment works better than taking ibuprofen arginine alone.

To participate, you need to be between the ages of 18 and 75 and have been medically diagnosed with carpal tunnel syndrome. You should also be able to understand and speak Spanish, and you must agree to take part in the study. If you join, you will receive either the combined treatment or just the ibuprofen arginine, and the team will monitor your progress. It's important to note that if you have certain health issues, have had recent surgery, or are pregnant, you might not be eligible for this trial. This study is currently recruiting participants, so if you're interested, you could help contribute to important research in managing carpal tunnel syndrome.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
  • Full understanding of written and spoken Spanish (language).
  • Participants must freely consent to participate.
  • The presence of positive Phalen an Tinel sings.
  • The presence of carpal tunnel syndrome signs and symptoms
  • Exclusion Criteria:
  • The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, kinesiophobia, deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy to gabapentin, allergy to ibuprofen arginine, and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive)

About Universidad Europea De Madrid

Universidad Europea de Madrid (UEM) is a leading academic institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, UEM is committed to fostering innovative research that contributes to the understanding and improvement of medical practices. The university collaborates with healthcare professionals and researchers to design and implement rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines. UEM's focus on interdisciplinary collaboration and cutting-edge research methodologies positions it as a pivotal player in the advancement of clinical knowledge and patient care.

Locations

Valencia, Carabobo, Venezuela

Patients applied

0 patients applied

Trial Officials

Francisco Unda, PhD

Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported